Armstrong Advisory Group’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Armstrong Advisory Group's NVS Position: Q3 2026 in Review
Armstrong Advisory Group held its Novartis (NVS) position steady in Q3 2026 at 116 shares worth $16.5K. The position accounts for ﹤0.01% of the portfolio, ranked #633.
Armstrong Advisory Group first reported a position in NVS in Q4 2022 and has held it in 16 quarters since. The position peaked at $18.2K in Q2 2026. 1,555 funds tracked by Wall St. Rank hold NVS as of Q3 2026.
- Armstrong Advisory Group held 116 shares of Novartis worth $16.5K as of Q3 2026.
- Armstrong Advisory Group left its Novartis share count unchanged in Q3 2026.
- Novartis made up ﹤0.01% of Armstrong Advisory Group's portfolio in Q3 2026, its #633 holding.
- Armstrong Advisory Group first reported a position in Novartis in Q4 2022 and has held it in 16 quarters since.
- Armstrong Advisory Group's Novartis position peaked at $18.2K in Q2 2026.
- 1,555 funds tracked by Wall St. Rank held Novartis as of Q3 2026.
Based on Armstrong Advisory Group's 13F filing for Q3 2026, filed 9 Oct 2026.